0,970  0,002  Monophenol monooxygenase inhibitor
0,968  0,001  UGT1A9 substrate
0,930  0,002  NOS2 expression inhibitor
0,924  0,001  Melanin inhibitor
0,908  0,003  Lipoxygenase inhibitor
0,901  0,001  UGT1A3 substrate
0,901  0,004  Chemoprotective
0,891  0,004  CYP2C19 substrate
0,888  0,002  UGT1A1 substrate
0,883  0,003  Skin whitener
0,884  0,004  Antioxidant
0,877  0,008  Apoptosis agonist
0,860  0,004  Chemopreventive
0,861  0,005  Caspase 9 stimulant
0,855  0,005  15-Lipoxygenase inhibitor
0,847  0,006  TNF expression inhibitor
0,845  0,004  UGT1A6 substrate
0,848  0,012  Alpha-glucosidase inhibitor
0,845  0,010  Transcription factor NF kappa B inhibitor
0,833  0,005  Antihypercholesterolemic
0,830  0,004  Free radical scavenger
0,817  0,013  Antiinflammatory
0,786  0,005  Sensitization
0,774  0,002  Neurotrophic factor enhancer
0,775  0,004  Antihypoxic
0,774  0,004  Caspase 3 stimulant
0,771  0,002  Amylase inhibitor
0,771  0,004  AR expression inhibitor
0,761  0,004  UDP-glucuronosyltransferase substrate
0,760  0,006  CYP1A2 substrate
0,748  0,005  Proliferative diseases treatment
0,746  0,004  Genotoxic
0,753  0,014  Antineoplastic (breast cancer)
0,743  0,004  Antimutagenic
0,724  0,002  Beta glucuronidase inhibitor
0,721  0,002  Estrogen receptor alpha antagonist
0,712  0,002  UGT2B15 substrate
0,709  0,004  MAO inhibitor
0,706  0,005  CYP1A2 inhibitor
0,705  0,005  Amyloid beta aggregation inhibitor
0,691  0,005  Histamine release inhibitor
0,689  0,006  Nitric oxide antagonist
0,685  0,008  12-Lipoxygenase inhibitor
0,673  0,005  CYP2C19 inhibitor
0,679  0,020  Antineoplastic (lung cancer)
0,675  0,017  Cyclophilin D inhibitor
0,675  0,017  Antidiabetic
0,657  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,651  0,006  Antineoplastic (brain cancer)
0,648  0,005  Antiamyloidogenic
0,648  0,009  Cytostatic
0,646  0,009  Spasmolytic
0,641  0,009  Antiosteoporotic
0,631  0,007  Apoptosis antagonist
0,629  0,005  Antihypertriglyceridemic
0,630  0,015  Respiratory analeptic
0,615  0,003  VCAM1 expression inhibitor
0,624  0,016  Carcinogenic
0,610  0,002  Antihemorrhagic
0,614  0,007  Hypoglycemic
0,604  0,003  Aromatase inhibitor
0,614  0,013  Bone diseases treatment
0,609  0,018  Antibacterial
0,595  0,006  Vascular (periferal) disease treatment
0,609  0,023  Antileukemic
0,587  0,009  Antineoplastic (glioma)
0,596  0,018  Prostate cancer treatment
0,579  0,003  SULT1A3 substrate
0,578  0,003  Xanthine oxidase inhibitor
0,586  0,012  Cardioprotectant
0,584  0,012  Hepatic disorders treatment
0,586  0,015  Mutagenic
0,586  0,025  Alzheimer's disease treatment
0,553  0,004  Lipid peroxidase inhibitor
0,565  0,016  Analeptic
0,574  0,026  Antineoplastic (colorectal cancer)
0,550  0,003  Estrogen receptor beta antagonist
0,556  0,013  Antiparasitic
0,559  0,016  CTGF expression inhibitor
0,546  0,009  Vasodilator
0,551  0,016  CYP2C9 inhibitor
0,559  0,026  Antineoplastic (colon cancer)
0,539  0,005  Hepatoprotectant
0,537  0,005  MAO B inhibitor
0,531  0,005  NOS3 expression enhancer
0,536  0,016  Cardiovascular analeptic
0,538  0,019  Cytotoxic
0,534  0,019  Antineoplastic (cervical cancer)
0,524  0,009  Antihelmintic
0,516  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,515  0,005  Protein-tyrosine phosphatase inhibitor
0,509  0,004  Estrogen antagonist
0,516  0,018  NOS3 expression inhibitor
0,507  0,009  Myocardial infarction treatment
0,507  0,011  Antineoplastic enhancer
0,514  0,020  Antineoplastic (pancreatic cancer)
0,494  0,005  Breast cancer-resistant protein inhibitor
0,500  0,014  Antineoplastic (glioblastoma multiforme)
0,488  0,003  Histidine decarboxylase inhibitor
0,506  0,022  Radioprotector
0,488  0,018  Antiprotozoal (Leishmania)
0,472  0,005  5-Lipoxygenase inhibitor
0,490  0,030  Antithrombotic
0,464  0,006  Sulfotransferase substrate
0,472  0,017  ICAM1 expression inhibitor
0,472  0,018  Antipyretic
0,480  0,026  Antineoplastic (melanoma)
0,479  0,026  Antifungal
0,481  0,030  Antineoplastic (ovarian cancer)
0,462  0,011  Antiulcerative
0,451  0,008  Antihypotensive
0,463  0,031  CYP2D6 substrate
0,475  0,045  CYP3A4 substrate
0,470  0,041  Immunosuppressant
0,432  0,009  Antineoplastic (squamous cell carcinoma)
0,433  0,012  UGT1A4 substrate
0,436  0,023  UGT2B4 substrate
0,425  0,014  P-glycoprotein inhibitor
0,448  0,038  Teratogen
0,412  0,004  Cholesterol synthesis inhibitor
0,407  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,428  0,033  Lipoprotein disorders treatment
0,396  0,003  Creatine kinase inhibitor
0,395  0,004  Estrogen agonist
0,419  0,029  Antineoplastic (non-small cell lung cancer)
0,410  0,023  Antidiabetic symptomatic
0,389  0,004  Gastritis treatment
0,392  0,012  UGT2B7 substrate
0,381  0,005  Cystathionine beta-synthase inhibitor
0,378  0,002  Ornithine decarboxylase inhibitor
0,373  0,003  Estrogen receptor beta agonist
0,377  0,008  Acetylcholinesterase inhibitor
0,387  0,024  Antineoplastic (osteosarcoma)
0,427  0,065  Antiparkinsonian
0,381  0,020  RNA-directed DNA polymerase inhibitor
0,365  0,010  MAO A inhibitor
0,354  0,003  Antiviral (Coronavirus)
0,354  0,003  Antiviral (SARS coronavirus)
0,353  0,005  Dementia treatment
0,375  0,029  Antineoplastic (renal cancer)
0,394  0,049  Streptokinase A inhibitor
0,350  0,005  Vascular dementia treatment
0,366  0,021  5 Hydroxytryptamine uptake stimulant
0,352  0,007  Alkaline phosphatase inhibitor
0,388  0,044  Embryotoxic
0,358  0,020  Dual specificity phosphatase inhibitor
0,356  0,018  Platelet adhesion inhibitor
0,366  0,030  Antineoplastic (liver cancer)
0,385  0,049  Aldehyde oxidase inhibitor
0,347  0,013  Topoisomerase II inhibitor
0,339  0,006  Heat shock protein 90 antagonist
0,336  0,005  Topoisomerase II alpha inhibitor
0,340  0,010  Cyclooxygenase 1 inhibitor
0,360  0,034  Superoxide dismutase inhibitor
0,364  0,038  Antineoplastic (multiple myeloma)
0,360  0,035  Tumour necrosis factor alpha release inhibitor
0,329  0,009  Chelator
0,360  0,041  Antidiabetic (type 2)
0,373  0,062  Angiogenesis inhibitor
0,313  0,008  Expectorant
0,313  0,012  Phospholipase A2 inhibitor
0,303  0,004  Mucolytic
0,302  0,005  AMP-activated protein kinase stimulant
0,317  0,020  Antineoplastic (carcinoma)
0,301  0,005  Electron transport complex I inhibitor
0,326  0,033  GST M1-1 substrate
0,303  0,013  Glutathione S-transferase substrate
0,331  0,046  Antiprotozoal (Trypanosoma)
0,295  0,012  DNA polymerase I inhibitor
0,299  0,016  Insulin sensitizer
0,361  0,086  Antiprotozoal
0,351  0,077  Stroke treatment
0,292  0,018  Protein kinase stimulant
0,277  0,003  Ca(v)3.1 blocker
0,281  0,011  LDLR expression enhancer
0,289  0,020  Cholinergic
0,288  0,019  Diabetic nephropathy treatment
0,291  0,025  Mcl-1 antagonist
0,303  0,040  Antineoplastic (sarcoma)
0,266  0,005  Postmenopausal disorders treatment
0,265  0,004  Lipase inhibitor
0,268  0,013  Antitussive
0,280  0,026  Antiviral (Herpes)
0,343  0,090  GABA C receptor rho-3 antagonist
0,301  0,048  Hypolipemic
0,302  0,050  Antineoplastic (lymphoma)
0,289  0,039  Peroxidase inhibitor
0,248  0,004  Estrogen receptor alpha agonist
0,252  0,009  Carbonic anhydrase XIII inhibitor
0,278  0,036  Antiviral (Influenza)
0,251  0,009  Androgen antagonist
0,265  0,024  Tubulin antagonist
0,330  0,089  CYP2C9 substrate
0,253  0,013  Interleukin 4 antagonist
0,245  0,011  UGT2B1 substrate
0,238  0,003  Fatty acid synthase inhibitor
0,332  0,101  Atherosclerosis treatment
0,243  0,013  Antibacterial (Helicobacter pylori)
0,250  0,020  UGT2B9 substrate
0,239  0,015  Antineoplastic antibiotic
0,254  0,030  Nitric-oxide synthase stimulant
0,249  0,025  Bone formation stimulant
0,317  0,098  Ulceration
0,222  0,004  Ca(v)3.2 blocker
0,223  0,008  NAD(P)H dehydrogenase (quinone) inhibitor
0,231  0,016  Neurotrophic factor
0,218  0,004  Xanthine dehydrogenase inhibitor
0,225  0,012  Carbonic anhydrase III inhibitor
0,217  0,005  DOPA decarboxylase inhibitor
0,213  0,004  Neuraminidase inhibitor
0,234  0,028  Antidote
0,219  0,015  SULT1A1 substrate
0,221  0,016  Farnesoid X receptor antagonist
0,228  0,025  Antidiarrheal
0,272  0,069  DNA damaging
0,244  0,042  Dual specificity phosphatase 3 inhibitor
0,226  0,026  M18 aspartyl aminopeptidase inhibitor
0,258  0,065  Antiglaucomic
0,202  0,010  Multidrug resistance-associated protein 1 inhibitor
0,268  0,076  Huntington's disease treatment
0,225  0,033  Cyclooxygenase inhibitor
0,280  0,088  Antimycobacterial
0,239  0,048  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,281  0,091  CYP3A4 inhibitor
0,248  0,060  Antimitotic
0,220  0,035  Antiviral (Influenza A)
0,193  0,010  HIV-1 integrase (3'-Processing) inhibitor
0,186  0,005  Carbonic anhydrase VII inhibitor
0,334  0,154  Antineoplastic (solid tumors)
0,184  0,008  Aldose reductase inhibitor
0,200  0,026  Topoisomerase I inhibitor
0,194  0,021  Microtubule formation inhibitor
0,194  0,021  Cyclooxygenase 3 inhibitor
0,209  0,038  Interferon gamma antagonist
0,223  0,055  Pneumotoxic
0,171  0,005  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,185  0,020  Coagulant
0,291  0,127  Antipruritic, allergic
0,169  0,006  Neuraminidase (influenza) inhibitor
0,207  0,046  VEGF expression inhibitor
0,171  0,010  SULT1E1 substrate
0,248  0,088  Transcription factor STAT inhibitor
0,220  0,060  DNA methyltransferase I inhibitor
0,195  0,038  Arachidonic acid antagonist
0,175  0,019  HDL-cholesterol increasing
0,196  0,040  UGT2B10 substrate
0,201  0,048  Liver fibrosis treatment
0,230  0,080  Antineoplastic (lymphocytic leukemia)
0,213  0,063  Abortion inducer
0,158  0,009  Alpha tubulin antagonist
0,269  0,122  Antiprotozoal (Plasmodium)
0,170  0,028  Butyrylcholinesterase inhibitor
0,160  0,019  Urease inhibitor
0,181  0,040  NADPH oxidase inhibitor
0,193  0,055  Succinate dehydrogenase inhibitor
0,161  0,025  Antineoplastic (uterine cancer)
0,233  0,098  Transcription factor STAT3 inhibitor
0,200  0,068  CYP2B6 inhibitor
0,145  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,176  0,045  Hemostatic
0,137  0,007  Estradiol 17 beta-dehydrogenase inhibitor
0,232  0,103  Antituberculosic
0,213  0,088  Angiogenesis stimulant
0,153  0,029  Carbonic anhydrase XV inhibitor
0,144  0,020  Phosphodiesterase 4D inhibitor
0,167  0,043  Cyclooxygenase 2 inhibitor
0,158  0,035  Beta amyloid protein antagonist
0,162  0,040  Alkylator
0,227  0,106  Immunostimulant
0,158  0,041  Antihelmintic (Trematoda)
0,133  0,017  Peroxisome proliferator-activated receptor gamma agonist
0,137  0,021  UGT2B11 substrate
0,119  0,004  Transcription factor RelA inhibitor
0,125  0,012  Antiviral (Hepatitis A)
0,145  0,032  Antiviral (Influenza B)
0,152  0,039  Gout treatment
0,140  0,027  Uric acid excretion stimulant
0,176  0,065  Heat shock protein 90 alpha antagonist
0,170  0,064  Interleukin 6 antagonist
0,121  0,015  Leukotriene antagonist
0,118  0,017  Na+ K+ transporting ATPase inhibitor
0,131  0,033  Toll-Like receptor 4 antagonist
0,103  0,005  Retinoid X alpha receptor agonist
0,116  0,020  CDC25A inhibitor
0,122  0,026  Antibiotic
0,123  0,031  Actinic keratosis treatment
0,183  0,091  DNA methylase inhibitor
0,116  0,025  Opioid kappa receptor antagonist
0,111  0,020  Leukotriene synthesis inhibitor
0,109  0,018  SULT1A2 substrate
0,150  0,059  Antifungal enhancer
0,136  0,046  Carcinogenic, group 2B
0,096  0,007  Glucose-6-phosphate translocase inhibitor
0,109  0,020  HIV-1 integrase inhibitor
0,148  0,061  Antifungal (Cryptococcus)
0,166  0,084  Antineoplastic (gastric cancer)
0,113  0,032  Carbonic anhydrase VI inhibitor
0,120  0,039  Anabolic
0,211  0,132  Gastrin inhibitor
0,165  0,086  Amyloid beta precursor protein antagonist
0,090  0,013  Leukotriene B4 antagonist
0,141  0,066  Psychosexual dysfunction treatment
0,136  0,062  Antiseptic
0,160  0,085  Death-associated protein kinase 2 inhibitor
0,176  0,102  Cardiodepressant
0,123  0,050  Choleretic
0,201  0,131  Antineoplastic (bladder cancer)
0,082  0,012  Postcoital contraceptive
0,093  0,024  Beta tubulin antagonist
0,128  0,059  Proteasome inhibitor
0,167  0,098  Non-steroidal antiinflammatory agent
0,077  0,008  Retinoid X receptor agonist
0,071  0,005  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,149  0,083  Thrombolytic
0,105  0,039  Bile acid receptor antagonist
0,180  0,117  Platelet antagonist
0,233  0,172  Antineoplastic (small cell lung cancer)
0,165  0,104  Psychostimulant
0,073  0,013  Cathepsin L2 inhibitor
0,124  0,065  Growth stimulant
0,158  0,100  Antineoplastic (bone cancer)
0,102  0,047  Opioid antagonist
0,116  0,062  Photosensitizer
0,137  0,082  Antiprotozoal (Coccidial)
0,140  0,088  GABA C receptor rho-2 antagonist
0,121  0,069  Contraceptive female
0,076  0,025  Transcription factor AP-1 inhibitor
0,149  0,099  Antipruritic, non-allergic
0,153  0,105  Toxic, respiratory center
0,086  0,041  Keratolytic
0,082  0,038  Antitreponemal
0,214  0,170  Vasodilator, coronary
0,130  0,086  Cell wall synthesis inhibitor
0,182  0,139  5 Hydroxytryptamine release stimulant
0,126  0,084  Histone deacetylase SIRT1 inhibitor
0,050  0,009  Catechol O-methyltransferase inhibitor
0,165  0,124  Aryl hydrocarbon receptor agonist
0,096  0,056  Antiviral (Rhinovirus)
0,096  0,056  ABCA1 expression enhancer
0,059  0,019  Opioid kappa receptor agonist
0,104  0,065  Mediator release inhibitor
0,135  0,096  Ca2+-transporting ATPase inhibitor
0,207  0,169  Vasodilator, peripheral
0,167  0,130  Antiviral (HIV)
0,211  0,174  GST A substrate
0,058  0,022  Squalene epoxidase inhibitor
0,072  0,036  CDC25B inhibitor
0,054  0,019  Neuraminidase (Influenza A) inhibitor
0,108  0,074  TRPA1 agonist
0,132  0,098  Adenylate cyclase stimulant
0,112  0,080  Alcohol dehydrogenase substrate
0,061  0,029  Acetyl-CoA transferase 2 inhibitor
0,041  0,010  Estrogen-related receptor beta antagonist
0,116  0,085  Antiacne
0,129  0,100  Eye irritation, high
0,047  0,017  Retinoic acid alpha receptor agonist
0,083  0,055  Thioredoxin reductase inhibitor
0,088  0,060  ATPase (Vacuolar H+) inhibitor
0,040  0,012  Leukotriene B4 receptor 1 antagonist
0,058  0,032  Dihydroorotate oxidase inhibitor
0,179  0,154  Antineurogenic pain
0,098  0,073  Skin irritative effect
0,037  0,015  ATP citrate lysase inhibitor
0,099  0,079  GABA C receptor antagonist
0,041  0,023  5-Alpha-reductase inhibitor
0,074  0,056  Analgesic, opioid
0,052  0,037  Vanilloid 2 antagonist
0,224  0,209  DNA directed DNA polymerase inhibitor
0,089  0,074  Alpha 2d adrenoreceptor antagonist
0,036  0,021  Tubulin agonist
0,143  0,129  Antieczematic atopic
0,067  0,054  Secretase beta inhibitor
0,033  0,020  Cholesterol ester transfer protein antagonist
0,059  0,047  Opioid delta receptor antagonist
0,067  0,055  Telomerase inhibitor
0,085  0,073  Prolactin inhibitor
0,138  0,127  Interleukin antagonist
0,024  0,013  Leukotriene B4 receptor 2 antagonist
0,037  0,027  Glucose-6-phosphate dehydrogenase inhibitor
0,024  0,014  Dopamine D1 agonist
0,071  0,064  Narcotic antagonist
0,076  0,070  Inducible nitric-oxide synthase inhibitor
0,048  0,042  Opioid agonist
0,180  0,175  Tyrosine 3 hydroxylase inhibitor
0,098  0,095  Autism spectrum disorders treatment
0,054  0,051  Antidote, heavy metal
0,018  0,016  Inosine monophosphate dehydrogenase 1 inhibitor
0,028  0,026  Squalene synthetase inhibitor
0,039  0,037  Cholesterol absorption inhibitor
0,081  0,080  Thioredoxin inhibitor
0,037  0,037  Leukocyte elastase inhibitor

